# OnCo record immunitybio (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/immunitybio/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "immunitybio" ;
  schema:name "ImmunityBio"@en ;
  schema:alternateName "Altor BioScience"@en ;
  schema:description "ImmunityBio makes Anktiva, the IL-15 superagonist approved with BCG for bladder cancer in 2024."@en ;
  schema:url <https://onco.cc/companies/immunitybio/>, <https://immunitybio.com> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://immunitybio.com> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/urothelial/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:drugs <https://onco.cc/drugs/nogapendekin-alfa/>, <https://onco.cc/drugs/cd19-t-hank/> ;
  onco:trials <https://onco.cc/trials/nct06710288/>, <https://onco.cc/trials/nct03228667/>, <https://onco.cc/trials/nct06061809/>, <https://onco.cc/trials/nct06745908/>, <https://onco.cc/trials/nct02138734/>, <https://onco.cc/trials/nct07125872/>, <https://onco.cc/trials/nct04390399/> .